Search Results

Refine Search

News & Features

‘Masking only works for so long’: Working with ADHD

Being a lawyer with ADHD is far from easy due to widespread misconceptions about the condition but there are ways to offer support, says Lisa Mueller of Casimir Jones. 1 August 2024

Big Pharma

Amgen v Sanofi/Regeneron in Japan: Function, sequence, mechanism

Amgen patents declared valid in Germany and Japan have also been deemed invalid by the European Patent Office, US Supreme Court, and in a separate Japan decision: but why? Takanori Abe of Abe & Partners examines the details. 19 March 2024

Americas

Gilead scores win in fake HIV drug dispute

New York court grants Gilead’s contempt motion | Defendant violated asset freeze order by selling and mortgaging properties 19 September 2024

Careers

Polsinelli grows roster with ex-corporate counsel

Prior to his new role, the senior hire spent eight years as an in-house counsel at a major pharma company. 19 September 2024

Unified Patent Court

‘Don’t rely on national case law’ at the UPC: Wouter Pors, Bird & Bird

The founding partner of Bird & Bird’s Dutch office explores his recent victory for Edwards Lifesciences and his active role at the court. 19 September 2024

Americas

Sandoz wins $137.2m payout for lost profits in generic launch

Court finds United Therapeutics breached settlement agreement by restricting distribution of cartridges | Sandoz alleged rival hampered launch of generic medication for pulmonary arterial hypertension 17 September 2024

Unified Patent Court

Dexcom suffers second patent revocation at hands of UPC

The court rejected the medical device company’s auxiliary requests and nixed patent in 17 territories although it seems receptive to these amendments in general, say Laura Orlando and Rachel Montagnon of Herbert Smith Freehills. 17 September 2024

Biotechnology

Sanofi signs global rights deal to develop rare cancer therapy

Sanofi will be responsible for global commercialisation of the medicine, used to treat neuroendocrine tumours | Pharma giant will pay up to $320m plus royalties to two biotech companies. 13 September 2024

Unified Patent Court

Unified Patent Court visualised: Cases, divisions, and classes in charts

Data visualisations based on the court’s activity from June to August reveal that the use of English is growing, German divisions are dominating, and appeals are creeping up, writes Marisa Woutersen. 12 September 2024

Careers

WBD to merge with firm to create ‘powerhouse’ practice

Deal marks the third major M&A to be announced so far this month | Combined firms have a total gross revenue of more than $742 million | Business marriage seen as “natural fit and clear win-win”. 12 September 2024